TTC12
protein-codingtetratricopeptide repeat domain 12, the group of Armadillo like helical domain containing|Tetratricopeptide repeat domain containing
Gene summary
Involved in axonemal dynein complex assembly and sperm axoneme assembly. Located in centrosome and cytoplasm. Implicated in acute lymphoblastic leukemia; alcohol dependence; drug dependence (multiple); nicotine dependence; and primary ciliary dyskinesia 45. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~69.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032924
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032924
Submitter: ClinGen
The tetratricopeptide repeat domain 12 (*TTC12*) gene encodes a cytoplasmic protein of the tetratricopeptide repeat gene family. The gene was first shown to function in dynein assembly in motile cilia and flagella and was first implicated in primary ciliary dyskinesia in 2020 (Thomas et al., PMID: 31978331). Common patient phenotypes included recurrent upper and lower respiratory infections, bronchiectasis, and respiratory ciliary axonemes characterized by absence of inner dynein arms and varying degrees of disorganization detected by transmission electron microscopy, and male infertility due to asthenospermia (PMID: 31978331). Per criteria outlined by the ClinGen Lumping & Splitting Working Group, we found the molecular mechanism and autosomal recessive mode of inheritance to be consistent among unrelated patients, while the phenotypic variability among them appeared to represent a spectrum of disease rather than separate disease entities. Therefore, the asserted cases associated with *TTC12 *variants, were curated for a single disease entity, primary ciliary dyskinesia, 45 (MONDO: 0032924). This curation includes 11 variants (splice site, nonsense, frameshift and missense) reported in four publications (PMID: 31978331, PMID: 36273201, PMID: 37325566, PMID: 38992144). Absence of TTC12 immunofluorescence signal from proband samples was consistent with a loss-of-function mechanism of pathogenicity. Experimental evidence supporting this gene disease relationship includes transmission electron microscopic analysis of sperm cells from patients carrying biallelic *TTC12* variants, revealing total lack of both inner and outer dynein arms and diminished TTC12 and DNAH17 signals in the patient spermatozoa relative to controls (PMID: 31978331, PMID: 37325566). Knockdown of TTC12a+b in Paramecia recapitulated the sperm phenotype and led to loss of both ODAs and IDAs. The swimming velocity and cell death observed in TTC12a-depleted cells were successfully rescued by the expression of an RNAi-resistant version of the gene (PMID: 31978331). In summary, *TTC12* is definitively associated with autosomal recessive primary ciliary dyskinesia 45. This has been repeatedly demonstrated in both research and diagnostic settings and has been upheld over time without the emergence of contradictory evidence. This classification was approved by the ClinGen Motile Ciliopathy GCEP on May 8th, 2025 (SOP version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0032924
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0016575
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0032924
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032924
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Genitourinary; Pulmonary
Intervention: Allergy/Immunology/Infectious; Pulmonary
Rationale: Pulmonary surveillance may be beneficial to assess respiratory function and institute early management measures; In order to facilitate mucus clearance, aggressive interventions (eg, chest percussion and oscillatory vest), as well as vaccinations and early and aggressive treatment of respiratory infections may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TTC12 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017868.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 1 | 10 | |||
| missense | 2 | 97 | 12 | 111 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 3 | 2 | 5 | |||
| splice donor/acceptor (+/-2bp) | 2 | 1 | 3 | |||
| Total | 7 | 2 | 99 | 21 | 2 | 131 |
Highest pathogenic variant AF is 0.00010782179
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060338.3 | 21 | MANE Select | |
| Ensembl | ENSP00000433757.1 | 21 | MANE Select | |
| RefSeq | NP_001305462.1 | 21 | Standard | |
| RefSeq | NP_001338966.1 | 20 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Cellular Component
- centrosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000529221
- Coding exons
- 21
- Length
- 69016
- Individuals with no LoFs
- 124730
- Homozygous LoFs
- 10
- Heterozygous LoFs
- 1008
- Defined
- 125748
- p
- 0.00406
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.0927 | 382 | 377 | 1.01 | 0.0000197 | 4622 |
| Missense (PolyPhen) | 88 | 95.749 | 0.91907 | 1164 | ||
| Synonymous | -0.398 | 150 | 144 | 1.04 | 0.00000797 | 1326 |
| Loss of Function | 1.31 | 31 | 39.9 | 0.777 | 0.00000204 | 495 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00092 | 0.00092 | rare |
| Latino/Admixed American | 0.019 | 0.019 | notable |
| Ashkenazi Jewish | 0.00060 | 0.00060 | rare |
| East Asian | 0.011 | 0.011 | notable |
| Finnish | 0.00037 | 0.00037 | rare |
| European (Non-Finnish) | 0.00070 | 0.00069 | rare |
| South Asian | 0.0018 | 0.0016 | notable |
| Other | 0.0029 | 0.0029 | notable |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.0969
Intolerance Scores
- LoFtool
- 0.911
- RVIS EVS
- -0.15
- RVIS percentile EVS
- 42.25
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.599
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |